Xamiol®-LEO Pharma´s new drug for treatment of scalp psoriasis -has been approved in 16 European countries. The UK will be the first country to market Xamiol®. This will take place already in the ...
Denmark’s Leo Pharma is celebrating the news that its new drug for scalp psoriasis, Xamiol, has been approved in 16 European countries. Denmark’s Leo Pharma is celebrating the news that its new drug ...
Xamiol® - el nuevo fármaco para el tratamiento de la soriasis del cuero cabelludo de LEO Pharma - ha sido aprobado en 16 países europeos. Reino Unido será el primer país en comercializar Xamiol® en el ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results